Keep up to date about urgent public health incidents with public information officers; federal, state, territorial, tribal, and local public health practitioners; clinicians; and public health laboratories in the ID field.
Since early 2017, CDC has observed an increase in the number of community-wide hepatitis A outbreaks in multiple states.
CDC is advising that U.S. consumers not eat any romaine lettuce, and retailers and restaurants not serve or sell any, until we learn more about the outbreak.
Since early 2017, the Centers for Disease Control and Prevention (CDC) has observed an increase in the number of community-wide hepatitis A outbreaks in multiple states.
Exposure to flood waters does not increase the risk of tetanus, so tetanus immunization campaigns are not needed for evacuees from flooding disasters.
CDC advises retailers not to serve or sell recalled ground beef from Cargill Meat Solutions because it may be contaminated with E. coli O26.
The Israeli Ministry of Health is reporting an outbreak of leptospirosis in persons with exposure to natural water sources in the Golan Heights region of northern Israel after July 1, 2018. As of September 6, 2018, three persons with leptospirosis who traveled to Israel have been identified in the United States, with additional suspected cases reported and under investigation.
The U.S. is experiencing steep, sustained increases in sexually transmitted diseases.
Appropriate fluoroquinolone prescribing is important for patient safety.
CDC has been responding and coordinating with the Ministry of Health of the Democratic Republic of the Congo (DRC) since a new outbreak of Ebola in North Kivu province was reported on July 30, 2018.
CDC and public health and regulatory officials in several states are investigating a multistate outbreak of Salmonella Reading infections linked to raw turkey products.
CDC, several states, and the U.S. Food and Drug Administration are investigating a multistate outbreak of Shiga toxin-producing E. coli O157:H7 infections (STEC O157:H7) in 13 states.
CDC has updated the 2011 recommendations for use of once-weekly isoniazid-rifapentine for 12 weeks (3HP) for treatment of latent TB infection.